|
|
||||||||
The Journal of Immunology, Vol 155, Issue 5 2468-2476, Copyright © 1995 by American Association of Immunologists
ARTICLES |
WW Kwok, GT Nepom and FC Raymond
Virginia Mason Research Center, Seattle, WA 98101, USA.
The impact of HLA-DQ allelic polymorphism on peptide binding interactions was investigated. MHC class II binding peptides from lambda repressor (lambda R), thyroid peroxidase (TPO), and a modified poly-alanine peptide (AKY) were used in two different binding assays, one with purified DQ molecules and another with cells that expressed DQ cell surface dimers. Class II heterodimers of different combinations of DQ alpha-chain and the DQ beta-chain independently influenced specific peptide interactions. Each of the peptides tested bound differentially to DQ alleles: TPO632-645 bound test to DQ2 molecules (DQA1*0501/DQB1*0201), lambda R12-24 bound best to DQ8 molecules (DQ3.2 or DQA1*0301/DQB1*0302), and AYK bound best to DQ1 (DQA*0102/DQB*0602) and DQ7 (DQ3.1 OR DQA1*0301/DQB1*0301). However, in each case in which either the DQ alpha- or DQ beta-chain was exchanged, major alterations or reversals of this pattern of interaction were observed. The interaction of lambda R with DQ8 was highly dependent on specific sequence polymorphisms at residue 57; an Ala-->Asp substitution on the DQ beta-chain at the polymorphic codon 57 prevented peptide binding. However, Ala 57 alone was not sufficient to permit binding in other DQ allelic contexts. These studies demonstrate the critical role of specific DQ polymorphisms in establishing the nature of bound Ag and thereby influencing the potential immune repertoire. Analysis of the ability of DQ molecules to bind and present antigenic peptides should aid in understanding their role in immunity and in development of HLA- DQ-associated autoimmune disease.
This article has been cited by other articles:
![]() |
M. E. Couch, R. L. Ferris, J. A. Brennan, W. M. Koch, E. M. Jaffee, M. S. Leibowitz, G. T. Nepom, H. A. Erlich, and D. Sidransky Alteration of Cellular and Humoral Immunity by Mutant p53 Protein and Processed Mutant Peptide in Head and Neck Cancer Clin. Cancer Res., December 1, 2007; 13(23): 7199 - 7206. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Steere, W. Klitz, E. E. Drouin, B. A. Falk, W. W. Kwok, G. T. Nepom, and L. A. Baxter-Lowe Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide J. Exp. Med., April 17, 2006; 203(4): 961 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ettinger, G. K. Papadopoulos, A. K. Moustakas, G. T. Nepom, and W. W. Kwok Allelic Variation in Key Peptide-Binding Pockets Discriminates between Closely Related Diabetes-Protective and Diabetes-Susceptible HLA-DQB1*06 Alleles J. Immunol., February 1, 2006; 176(3): 1988 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Senger, F. Maurano, M. F. Mazzeo, M. Gaita, O. Fierro, C. S. David, R. Troncone, S. Auricchio, R. A. Siciliano, and M. Rossi Identification of Immunodominant Epitopes of {alpha}-Gliadin in HLA-DQ8 Transgenic Mice following Oral Immunization J. Immunol., December 15, 2005; 175(12): 8087 - 8095. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Uthman and M Khamashta Ethnic and geographical variation in antiphospholipid (Hughes) syndrome Ann Rheum Dis, December 1, 2005; 64(12): 1671 - 1676. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Veldman, K. L. Gebhard, W. Uter, R. Wassmuth, J. Grotzinger, E. Schultz, and M. Hertl T Cell Recognition of Desmoglein 3 Peptides in Patients with Pemphigus Vulgaris and Healthy Individuals J. Immunol., March 15, 2004; 172(6): 3883 - 3892. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Diaz, M. Amicosante, D. Jaraquemada, R. H. Butler, M. V. Guillen, M. Sanchez, C. Nombela, and J. Arroyo Functional analysis of HLA-DP polymorphism: a crucial role for DP{beta} residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding Int. Immunol., May 1, 2003; 15(5): 565 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Cohen, J. Gichui, R. Rukaria, S. S. Sinei, L. K. Gaur, and R. C. Brunham Immunogenetic Correlates for Chlamydia trachomatis-Associated Tubal Infertility Obstet. Gynecol., March 1, 2003; 101(3): 438 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sidney, M.-F. del Guercio, S. Southwood, and A. Sette The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity J. Immunol., November 1, 2002; 169(9): 5098 - 5108. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Alleva, A. Gaur, L. Jin, D. Wegmann, P. A. Gottlieb, A. Pahuja, E. B. Johnson, T. Motheral, A. Putnam, P. D. Crowe, et al. Immunological Characterization and Therapeutic Activity of an Altered-Peptide Ligand, NBI-6024, Based on the Immunodominant Type 1 Diabetes Autoantigen Insulin B-Chain (9-23) Peptide Diabetes, July 1, 2002; 51(7): 2126 - 2134. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Snijders, D. G. Elferink, A. Geluk, A. L. van der Zanden, K. Vos, G. M. T. Schreuder, F. C. Breedveld, R. R. P. de Vries, and E. H. Zanelli An HLA-DRB1-Derived Peptide Associated with Protection Against Rheumatoid Arthritis Is Naturally Processed by Human APCs J. Immunol., April 15, 2001; 166(8): 4987 - 4993. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Caliz, T. Atsumi, E. Kondeatis, O. Amengual, M. A. Khamashta, R. W. Vaughan, J. S. Lanchbury, and G. R. V. Hughes HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients Rheumatology, January 1, 2001; 40(1): 31 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ettinger, A. W. Liu, G. T. Nepom, and W. W. Kwok {beta}57-Asp Plays an Essential Role in the Unique SDS Stability of HLA-DQA1*0102/DQB1*0602 {alpha}{beta} Protein Dimer, the Class II MHC Allele Associated with Protection from Insulin-Dependent Diabetes Mellitus J. Immunol., September 15, 2000; 165(6): 3232 - 3238. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. HONDA, K. TAKAKUWA, I. HATAYA, M. YASUDA, T. KURABAYASHI, and K. TANAKA HLA-DQB1 and HLA-DPB1 Genotypes in Severe Preeclampsia Obstet. Gynecol., September 1, 2000; 96(3): 385 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Moustakas, Y. van de Wal, J. Routsias, Y. M. C. Kooy, P. van Veelen, J. W. Drijfhout, F. Koning, and G. K. Papadopoulos Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes Int. Immunol., August 1, 2000; 12(8): 1157 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Reijonen, J. F. Elliott, P. van Endert, and G. Nepom Differential Presentation of Glutamic Acid Decarboxylase 65 (GAD65) T Cell Epitopes Among HLA-DRB1*0401-Positive Individuals J. Immunol., August 1, 1999; 163(3): 1674 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Pearson, A. M. Gautam, I. C. Rulifson, R. S. Liblau, and H. O. McDevitt A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11 PNAS, January 5, 1999; 96(1): 197 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-K Sire, H Julkunen, R Kaaja, and H Ekblad Role of HLA in congenital heart block: susceptibility alleles in children Lupus, January 1, 1999; 8(1): 60 - 67. [Abstract] [PDF] |
||||
![]() |
L. van de Corput, H. C. Kluin-Nelemans, M. G.D. Kester, R. Willemze, and J.H. F. Falkenburg Hairy Cell Leukemia-Specific Recognition by Multiple Autologous HLA-DQ or DP-Restricted T-Cell Clones Blood, January 1, 1999; 93(1): 251 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Steele, S. P. Young, J. C. Goodall, and P. H. Gallimore Structural Aspects of the Interaction Between Heterogeneic Human Papillomavirus Type 1 E4-Specific T Cell Receptors and the Same Peptide/HLA-DQ8 Complex J. Immunol., November 1, 1998; 161(9): 4745 - 4752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Anderton, S. P. Manickasingham, C. Burkhart, T. A. Luckcuck, S. J. Holland, A. G. Lamont, and D. C. Wraith Fine Specificity of the Myelin-Reactive T Cell Repertoire: Implications for TCR Antagonism in Autoimmunity J. Immunol., October 1, 1998; 161(7): 3357 - 3364. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Doherty, J. E. Penzotti, D. M. Koelle, W. W. Kwok, T. P. Lybrand, S. Masewicz, and G. T. Nepom Structural Basis of Specificity and Degeneracy of T Cell Recognition: Pluriallelic Restriction of T Cell Responses to a Peptide Antigen Involves Both Specific and Promiscuous Interactions Between the T Cell Receptor, Peptide, and HLA-DR J. Immunol., October 1, 1998; 161(7): 3527 - 3535. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Bourdette, Y. K. Chou, R. H. Whitham, J. Buckner, H. J. Kwon, G. T. Nepom, A. Buenafe, S. A. Cooper, M. Allegretta, G. A. Hashim, et al. Immunity to T Cell Receptor Peptides in Multiple Sclerosis. III. Preferential Immunogenicity of Complementarity-Determining Region 2 Peptides from Disease-Associated T Cell Receptor BV Genes J. Immunol., July 15, 1998; 161(2): 1034 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ettinger and W. W. Kwok A Peptide Binding Motif for HLA-DQA1*0102/DQB1*0602, the Class II MHC Molecule Associated with Dominant Protection in Insulin-Dependent Diabetes Mellitus J. Immunol., March 1, 1998; 160(5): 2365 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Petersdorf, G. M. Longton, C. Anasetti, E. M. Mickelson, A. G. Smith, P. J. Martin, and J. A. Hansen Definition of HLA-DQ as a transplantation antigen PNAS, December 24, 1996; 93(26): 15358 - 15363. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |